Everest Organics Limited exchange about the Outcome of Board Meeting held on August 05, 2025 .
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) along with the limited review report from statutory auditors. Dr. Srikakarlapudi Sirisha was re-appointed as Managing Director and Mr. Srikakarlapudi Harikrishna as Whole-time Director, both subject to shareholder approval at the upcoming AGM. Ms. Shweta Singh was appointed as the new Company Secretary and Compliance Officer. The Board also approved the Board's Report for FY25 and the notice for the 32nd Annual General Meeting scheduled for September 27, 2025, to be held via video conferencing.
This is a routine quarterly update with no major surprises. Shareholders can expect stable promoter-led leadership, and the new Company Secretary appointment suggests continuity in compliance. The Q1 results would be the key driver of near-term stock reaction.